New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-21-003 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites research to develop, characterize, and validate new, unconventional, or innovative non-rodent mammalian models of late-onset (sporadic) Alzheimer's Disease (AD). These new models are expected torecapitulate molecular, cellular, neuropathological, behavioral, and/or cognitive hallmarks and aspects of late-onset AD.Research supported under this FOA is expected to provide new investigativetools to identify the gaps in current knowledge related to molecular mechanisms of late-onset AD and identify potential therapeutic targets.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding